Answers are grounded in this paper and cite their sources.
Feasibility trial reveals that continuous glucose monitoring is acceptable for youth with obesity, suggesting potential for health improvement.
BACKGROUND: Continuous glucose monitors (CGM) offer real-time biofeedback that might support behavioural changes to reduce obesity in youth. However, the feasibility and acceptability of CGM in this population remain underexplored. METHODS: A 6-week crossover trial was conducted with youth aged 10-18 years with a body mass index above the 95th percentile. Participants experienced two phases in random order: (1) masked CGM (without data access) and (2) unmasked CGM (with real-time data access). The primary objective was to assess feasibility through recruitment, retention and adherence rates. Secondary measures included CGM-derived glucose metrics, sleep patterns, dietary intake, physical activity, eating behaviours and weight change. Descriptive analyses and mixed-effects regression models were used to examine between-condition differences on an intention-to-treat basis. RESULTS: Of 30 eligible participants, 27 were enrolled (90% recruitment rate; age: 14.5 ± 2.2 years, HbA1c: 5.5 ± 0.24%, 15/27 [55%] Hispanic, 16/27 [59%] female). Of the enrolled participants, 24 completed the protocol. Adherence averaged 35.1 days over 42 days (87% of days). The CGM was well tolerated, with no adverse effects reported. There was no significant difference in glycaemic variability metrics between masked and unmasked conditions over the 6-week period. CONCLUSIONS: This trial supports the feasibility and acceptability of CGM use in youth with obesity. Given the exploratory nature of this study, longer-term research is needed to evaluate its effectiveness in modifying health behaviours and metabolic outcomes in this population.
No takes yet. Share an insight, caveat, or question.
Chimatapu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: